BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36135)

  • 1. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
    Williams JW; Morrison JF; Duggleby RG
    Biochemistry; 1979 Jun; 18(12):2567-73. PubMed ID: 36135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic characterization of the interactions of methotrexate with dihydrofolate reductase by quantitative affinity chromatography.
    Waltham MC; Holland JW; Nixon PF; Winzor DJ
    Biochem Pharmacol; 1988 Feb; 37(3):541-5. PubMed ID: 3122765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of isomerization of initial complexes in the binding of inhibitors to dihydrofolate reductase.
    Blakley RL; Cocco L
    Biochemistry; 1985 Aug; 24(18):4772-7. PubMed ID: 4074660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical mechanism of the reaction catalyzed by dihydrofolate reductase from Streptococcus faecium: pH studies and chemical modification.
    Williams JW; Morrison JF
    Biochemistry; 1981 Oct; 20(21):6024-9. PubMed ID: 7306491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic study of the influence of NADPH on the binding of methotrexate and its metabolites to a mammalian dihydrofolate reductase.
    Gilli RM; Sari JC; Sica LM; Briand CM
    Biochim Biophys Acta; 1988 Jan; 964(1):53-60. PubMed ID: 3334873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 1,N6-ethenoadenine derivatives of triphosphopyridine and reduced triphosphopyridine nucleotides with dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Biochemistry; 1976 Sep; 15(18):4042-7. PubMed ID: 9129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses.
    Baccanari DP; Joyner SS
    Biochemistry; 1981 Mar; 20(7):1710-6. PubMed ID: 7013798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli.
    Appleman JR; Howell EE; Kraut J; Kühl M; Blakley RL
    J Biol Chem; 1988 Jul; 263(19):9187-98. PubMed ID: 3288632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence study of substrate and inhibitor binding to bovine liver dihydrofolate reductase.
    Degan P; Carpano P; Cercignani G; Montagnoli G
    Int J Biochem; 1989; 21(3):291-5. PubMed ID: 2744204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase.
    Appleman JR; Prendergast N; Delcamp TJ; Freisheim JH; Blakley RL
    J Biol Chem; 1988 Jul; 263(21):10304-13. PubMed ID: 3292526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of dihydrofolate reductase. I. Inactivation of bacterial dihydrofolate reductase concomitant with modification of a methionine residue at the active site.
    Gleisner JM; Blakley RL
    J Biol Chem; 1975 Feb; 250(4):1580-7. PubMed ID: 1112818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.
    Nakano T; Spencer HT; Appleman JR; Blakley RL
    Biochemistry; 1994 Aug; 33(33):9945-52. PubMed ID: 8061003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of N-bromosuccinimide modification on dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli. Activity, spectrophotometric, fluorescence and circular dichroism studies.
    Williams MN
    J Biol Chem; 1975 Jan; 250(1):322-30. PubMed ID: 237891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear magnetic resonance study of nicotinamide adenine dinucleotide phosphate binding to Lactobacillus casei dihydrofolate reductase.
    Way JL; Birdsall B; Feeney J; Roberts GC; Burgen AS
    Biochemistry; 1975 Jul; 14(15):3470-5. PubMed ID: 238594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human dihydrofolate reductase: reduction of alternative substrates, pH effects, and inhibition by deazafolates.
    Williams EA; Morrison JF
    Biochemistry; 1992 Jul; 31(29):6801-11. PubMed ID: 1637816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tightly bound substrates in pure preparations of dihydrofolate reductase: implications for studies on enzymes.
    Williams EA; Morrison JF
    Biochim Biophys Acta; 1991 May; 1078(1):47-55. PubMed ID: 2049383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of coenzyme analogues to Lactobacillus casei dihydrofolate reductase: binary and ternary complexes.
    Birdsall B; Burgen AS; Roberts GC
    Biochemistry; 1980 Aug; 19(16):3723-31. PubMed ID: 6773548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic mechanism of the dihydrofolate reductase reaction as determined by pH studies.
    Stone SR; Morrison JF
    Biochemistry; 1984 Jun; 23(12):2753-8. PubMed ID: 6380573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.